RFL
Rafael Holdings, Inc.
Price Chart
Latest Quote
$2.73
| Previous Close | $2.63 |
| Open | $2.58 |
| Day High | $2.80 |
| Day Low | $2.47 |
| Volume | 386,356 |
Stock Information
| Shares Outstanding | 51.21M |
| Total Debt | $610K |
| Cash Equivalents | $30.50M |
| Revenue | $980K |
| Net Income | $-32.55M |
| Sector | Real Estate |
| Industry | Real Estate Services |
| Market Cap | $141.96M |
| EPS (TTM) | $-0.71 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $117.49M |
| Sales | $980K |
| Income | $-32.55M |
| Book/sh | $1.45 |
| Cash/sh | $0.60 |
| Employees | 21 |
Financial Ratios
| Quick Ratio | 2.79 |
| Current Ratio | 3.16 |
| Debt/Eq | 0.76 |
Returns & Margins
| ROA | -22.77% |
| ROE | -37.59% |
| Gross Margin | 95.10% |
| Operating Margin | -3837.99% |
Ownership
| Insider Ownership | 38.12% |
| Institutional Ownership | 7.33% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 144.86 |
| P/B | 1.88 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.75 |
| SMA50 | $1.47 |
| SMA200 | $1.34 |
| RSI | 85.79 |
| ATR | 0.2651 |
| Shares Float | 35.58M |
| Short Float | 0.31% |
| Short Ratio | 0.97 |
| Volatility | 0.54 |
| Rel Volume | 1.55 |
Performance History
| Week | +28.77% |
| Month | +102.22% |
| Quarter | +111.63% |
| 6 Months | +121.95% |
| YTD | +116.67% |
| Year | +40.72% |
| 3 Years | +25.83% |
| 5 Years | -93.67% |
| 10 Years | -43.51% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $2.73 | 386,400 |
| 2026-06-17 | $2.63 | 202,300 |
| 2026-06-16 | $2.54 | 386,100 |
| 2026-06-15 | $2.16 | 315,600 |
| 2026-06-12 | $2.24 | 899,600 |
| 2026-06-11 | $2.12 | 578,900 |
| 2026-06-10 | $1.78 | 291,500 |
| 2026-06-09 | $1.93 | 567,700 |
| 2026-06-08 | $1.63 | 515,100 |
| 2026-06-05 | $1.55 | 420,100 |
| 2026-06-04 | $1.39 | 53,100 |
| 2026-06-03 | $1.35 | 55,800 |
| 2026-06-02 | $1.37 | 64,000 |
| 2026-06-01 | $1.39 | 46,000 |
| 2026-05-29 | $1.37 | 39,900 |
| 2026-05-28 | $1.39 | 58,200 |
| 2026-05-27 | $1.37 | 30,000 |
| 2026-05-26 | $1.32 | 35,800 |
| 2026-05-22 | $1.34 | 15,200 |
| 2026-05-21 | $1.33 | 21,500 |
| 2026-05-20 | $1.37 | 37,300 |
| 2026-05-19 | $1.35 | 60,500 |
About Rafael Holdings, Inc.
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is Trappsol Cyclo, which is in phase 3 clinical trial being evaluated for the potential treatment of Niemann-Pick Disease Type C1 ("NPC1"), a rare, fatal and progressive genetic disorder; and CPI-613 (devimistat), a stable analog of normally transient, acylated catalytic intermediates of lipoate, which is in phase II of clinical trial. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1A and 1B clinical studies targeting patients with advanced cancers. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrument for Carpal Tunnel syndrome. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.
Income Statement (Annual)
| Metric | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | - | $154,000 | $0 | - |
| Cost Of Revenue | - | $154,000 | $0 | - |
| Total Revenue | - | $637,000 | $279,000 | $410,000 |
| Operating Revenue | - | $637,000 | $279,000 | $410,000 |
| Expenses | ||||
| Interest Expense | - | $248,000 | $0 | $6,000 |
| Total Expenses | - | $103,264,000 | $15,322,000 | $60,887,000 |
| Other Income Expense | - | $33,231,000 | $3,045,000 | $-79,690,000 |
| Other Non Operating Income Expenses | - | $31,423,000 | - | - |
| Net Non Operating Interest Income Expense | - | $2,135,000 | $3,253,000 | $195,000 |
| Interest Expense Non Operating | - | $248,000 | $0 | $6,000 |
| Operating Expense | - | $103,110,000 | $15,322,000 | $60,887,000 |
| General And Administrative Expense | - | $8,854,000 | $8,932,000 | $16,978,000 |
| Total Other Finance Cost | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | - | $-34,410,000 | $-8,354,000 | $-122,828,000 |
| Net Interest Income | - | $2,135,000 | $3,253,000 | $195,000 |
| Interest Income | - | $2,383,000 | $3,253,000 | $201,000 |
| Normalized Income | - | $-36,145,961 | $-11,310,209 | $-43,138,000 |
| Net Income From Continuing And Discontinued Operation | - | $-34,410,000 | $-1,876,000 | $-124,658,000 |
| Total Operating Income As Reported | - | $-102,627,000 | $-15,043,000 | $-60,477,000 |
| Net Income Common Stockholders | - | $-34,410,000 | $-1,876,000 | $-124,658,000 |
| Net Income | - | $-34,410,000 | $-1,876,000 | $-124,658,000 |
| Net Income Including Noncontrolling Interests | - | $-65,003,000 | $-2,215,000 | $-142,377,000 |
| Net Income Discontinuous Operations | - | $0 | $6,478,000 | $-1,830,000 |
| Net Income Continuous Operations | - | $-65,003,000 | $-8,693,000 | $-140,547,000 |
| Earnings From Equity Interest Net Of Tax | - | $-422,000 | $-203,000 | $-575,000 |
| Pretax Income | - | $-67,261,000 | $-8,745,000 | $-139,972,000 |
| Special Income Charges | - | $-1,633,000 | $-334,000 | $-79,141,000 |
| Interest Income Non Operating | - | $2,383,000 | $3,253,000 | $201,000 |
| Operating Income | - | $-102,627,000 | $-15,043,000 | $-60,477,000 |
| Depreciation Amortization Depletion Income Statement | - | $225,000 | $78,000 | $72,000 |
| Depreciation And Amortization In Income Statement | - | $225,000 | $78,000 | $72,000 |
| Gross Profit | - | $483,000 | $279,000 | - |
| Net Income Extraordinary | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-1.04 | $-1.43 | $-0.08 | $-6.22 |
| Basic EPS | $-1.04 | $-1.43 | $-0.08 | $-6.22 |
| Other | ||||
| Diluted Average Shares | $29,422,221 | $24,086,135 | $22,582,567 | $20,050,896 |
| Basic Average Shares | $29,422,221 | $24,086,135 | $22,582,567 | $20,050,896 |
| Tax Effect Of Unusual Items | - | $72,039 | $88,791 | $0 |
| Tax Rate For Calcs | - | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | - | $-68,596,000 | $-11,712,000 | $-60,204,000 |
| Total Unusual Items | - | $1,808,000 | $3,045,000 | $-79,690,000 |
| Total Unusual Items Excluding Goodwill | - | $1,808,000 | $3,045,000 | $-79,690,000 |
| Reconciled Depreciation | - | $225,000 | $78,000 | $72,000 |
| EBITDA (Bullshit earnings) | - | $-66,788,000 | $-8,667,000 | $-139,894,000 |
| EBIT | - | $-67,013,000 | $-8,745,000 | $-139,966,000 |
| Diluted NI Availto Com Stockholders | - | $-34,410,000 | $-1,876,000 | $-124,658,000 |
| Minority Interests | - | $30,593,000 | $339,000 | $17,719,000 |
| Tax Provision | - | $-2,680,000 | $-255,000 | $0 |
| Other Special Charges | - | $89,861,000 | - | - |
| Write Off | - | $0 | $334,000 | $79,141,000 |
| Restructuring And Mergern Acquisition | - | $1,633,000 | $0 | - |
| Gain On Sale Of Security | - | $3,441,000 | $3,379,000 | $-549,000 |
| Research And Development | - | $94,031,000 | $6,312,000 | $8,742,000 |
| Selling General And Administration | - | $8,854,000 | $8,932,000 | $16,978,000 |
| Other Gand A | - | $8,854,000 | $8,932,000 | $16,978,000 |
| Provision For Doubtful Accounts | - | - | $0 | $35,095,000 |
| Gain On Sale Of Ppe | - | - | - | - |
Balance Sheet (Annual)
| Metric | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $75,713,000 | $98,718,000 | $98,940,000 | $120,711,000 |
| Total Assets | $96,832,000 | $98,829,000 | $118,320,000 | $154,055,000 |
| Total Non Current Assets | $24,330,000 | $15,888,000 | $9,973,000 | $139,291,000 |
| Other Non Current Assets | $35,000 | $9,000 | $1,387,000 | $42,915,000 |
| Non Current Note Receivables | $1,146,000 | $0 | - | - |
| Financial Assets | $2,547,000 | $4,984,000 | $4,764,000 | $5,268,000 |
| Goodwill And Other Intangible Assets | $6,472,000 | $1,575,000 | $1,575,000 | $1,575,000 |
| Other Intangible Assets | $3,422,000 | $1,575,000 | $1,575,000 | $1,575,000 |
| Current Assets | $72,502,000 | $82,941,000 | $108,347,000 | $14,764,000 |
| Other Current Assets | $430,000 | $914,000 | $4,621,000 | $1,075,000 |
| Receivables | $6,132,000 | $2,521,000 | $297,000 | $835,000 |
| Accrued Interest Receivable | $515,000 | $387,000 | $140,000 | $0 |
| Notes Receivable | $5,191,000 | $1,921,000 | $0 | - |
| Accounts Receivable | $426,000 | $213,000 | $157,000 | $235,000 |
| Allowance For Doubtful Accounts Receivable | $-245,000 | $-245,000 | $-197,000 | $-193,000 |
| Gross Accounts Receivable | $671,000 | $458,000 | $354,000 | $428,000 |
| Cash Cash Equivalents And Short Term Investments | $65,940,000 | $79,506,000 | $63,235,000 | $7,854,000 |
| Cash And Cash Equivalents | $2,675,000 | $21,498,000 | $26,537,000 | $7,854,000 |
| Investmentin Financial Assets | - | $4,763,000 | $0 | $79,141,000 |
| Assets Held For Sale Current | - | $0 | $40,194,000 | $0 |
| Restricted Cash | - | - | $0 | $5,000,000 |
| Prepaid Assets | - | - | $4,621,000 | $1,075,000 |
| Non Current Deferred Assets | - | - | - | $0 |
| Non Current Deferred Taxes Assets | - | - | - | $0 |
| Non Current Accounts Receivable | - | - | - | $7,500,000 |
| Debt | ||||
| Total Debt | $2,387,000 | - | $15,000,000 | $14,528,000 |
| Long Term Debt And Capital Lease Obligation | $73,000 | - | - | - |
| Long Term Debt | $73,000 | - | - | - |
| Current Debt And Capital Lease Obligation | $2,314,000 | - | $15,000,000 | $14,528,000 |
| Current Debt | $2,314,000 | - | $15,000,000 | $14,528,000 |
| Other Current Borrowings | $614,000 | - | - | $14,528,000 |
| Net Debt | - | - | - | $6,674,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $10,574,000 | $2,200,000 | $21,114,000 | $17,351,000 |
| Total Non Current Liabilities Net Minority Interest | $3,060,000 | $55,000 | $88,000 | $48,000 |
| Other Non Current Liabilities | $5,000 | $55,000 | $88,000 | $48,000 |
| Current Liabilities | $7,514,000 | $2,145,000 | $21,026,000 | $17,303,000 |
| Other Current Liabilities | $113,000 | $1,023,000 | $3,518,000 | $252,000 |
| Current Notes Payable | $1,700,000 | $0 | $15,000,000 | $14,528,000 |
| Payables And Accrued Expenses | $5,087,000 | $1,122,000 | $2,508,000 | $2,523,000 |
| Interest Payable | $213,000 | $0 | - | - |
| Payables | $3,289,000 | $359,000 | $633,000 | $1,296,000 |
| Accounts Payable | $2,556,000 | $333,000 | $564,000 | $1,160,000 |
| Equity | ||||
| Common Stock Equity | $82,185,000 | $100,293,000 | $100,515,000 | $122,286,000 |
| Total Equity Gross Minority Interest | $86,258,000 | $96,629,000 | $97,206,000 | $136,704,000 |
| Stockholders Equity | $82,185,000 | $100,293,000 | $100,515,000 | $122,286,000 |
| Gains Losses Not Affecting Retained Earnings | $3,802,000 | $3,372,000 | $3,704,000 | $3,772,000 |
| Retained Earnings | $-201,743,000 | $-167,333,000 | $-165,457,000 | $-40,799,000 |
| Long Term Equity Investment | $12,010,000 | $4,763,000 | $0 | $575,000 |
| Other Equity Adjustments | - | - | $-63,000 | $3,772,000 |
| Investments In Other Ventures Under Equity Method | - | - | - | $477,000 |
| Other | ||||
| Treasury Shares Number | $102,942 | $147,264 | - | $10,348 |
| Ordinary Shares Number | $24,960,089 | $24,625,943 | $24,826,212 | $17,978,270 |
| Share Issued | $25,063,031 | $24,773,207 | $24,826,212 | $17,988,618 |
| Tangible Book Value | $75,713,000 | $98,718,000 | $98,940,000 | $120,711,000 |
| Invested Capital | $84,572,000 | $100,293,000 | $115,515,000 | $136,814,000 |
| Working Capital | $64,988,000 | $80,796,000 | $87,321,000 | $-2,539,000 |
| Total Capitalization | $82,258,000 | $100,293,000 | $100,515,000 | $122,286,000 |
| Minority Interest | $4,073,000 | $-3,664,000 | $-3,309,000 | $14,418,000 |
| Foreign Currency Translation Adjustments | $3,691,000 | $3,725,000 | $3,767,000 | $3,772,000 |
| Unrealized Gain Loss | $111,000 | $-353,000 | $-63,000 | $0 |
| Treasury Stock | $168,000 | $0 | - | - |
| Additional Paid In Capital | $280,048,000 | $264,010,000 | $262,023,000 | $159,136,000 |
| Capital Stock | $246,000 | $244,000 | $245,000 | $177,000 |
| Common Stock | $246,000 | $244,000 | $245,000 | $177,000 |
| Non Current Accrued Expenses | $2,982,000 | $0 | - | - |
| Current Accrued Expenses | $1,798,000 | $763,000 | $1,875,000 | $1,227,000 |
| Dueto Related Parties Current | $733,000 | $26,000 | $69,000 | $136,000 |
| Investments And Advances | $12,010,000 | $7,625,000 | $477,000 | $80,193,000 |
| Other Investments | $0 | $2,862,000 | $477,000 | $477,000 |
| Investmentsin Associatesat Cost | $12,010,000 | $4,763,000 | $0 | $575,000 |
| Goodwill | $3,050,000 | $0 | - | - |
| Net PPE | $2,120,000 | $1,695,000 | $1,770,000 | $1,840,000 |
| Accumulated Depreciation | $-1,018,000 | $-878,000 | $-803,000 | $-731,000 |
| Gross PPE | $3,138,000 | $2,573,000 | $2,573,000 | $2,571,000 |
| Other Properties | $81,000 | $68,000 | $68,000 | $66,000 |
| Machinery Furniture Equipment | $552,000 | $0 | - | $1,145,000 |
| Buildings And Improvements | $2,505,000 | $2,505,000 | $2,505,000 | $2,505,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $63,265,000 | $58,008,000 | $36,698,000 | $0 |
| Available For Sale Securities | - | $4,763,000 | - | - |
| Investmentsin Joint Venturesat Cost | - | $2,797,000 | $0 | - |
| Duefrom Related Parties Non Current | - | - | $0 | $7,500,000 |
| Duefrom Related Parties Current | - | - | $0 | $600,000 |
| Investmentsin Subsidiariesat Cost | - | - | - | $79,141,000 |
| Land And Improvements | - | - | - | $10,412,000 |
Cash Flow Statement (Annual)
| Metric | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-7,980,000 | $-10,886,000 | $-26,081,000 | $-15,601,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-7,802,000 | $-10,886,000 | $-26,079,000 | $-15,601,000 |
| Cash From Discontinued Operating Activities | $0 | $-639,000 | $-41,000 | $-287,000 |
| Cash Flow From Continuing Operating Activities | $-7,802,000 | $-10,247,000 | $-27,868,000 | $-15,314,000 |
| Operating Gains Losses | $-1,800,000 | $-171,000 | $1,124,000 | $-5,890,000 |
| Investing Activities | ||||
| Capital Expenditure | $-178,000 | - | $-2,000 | $-206,000 |
| Investing Cash Flow | $-10,820,000 | $21,211,000 | $-63,796,000 | $-8,171,000 |
| Cash From Discontinued Investing Activities | $0 | $48,171,000 | $-113,000 | $-250,000 |
| Cash Flow From Continuing Investing Activities | $-10,820,000 | $-26,960,000 | $-63,683,000 | $-7,921,000 |
| Net Other Investing Changes | $-6,989,000 | $-2,000,000 | $-26,875,000 | $-16,623,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-168,000 | $0 | - | - |
| Financing Cash Flow | $-179,000 | $-15,218,000 | $103,864,000 | $30,298,000 |
| Cash From Discontinued Financing Activities | $0 | $-15,000,000 | $0 | $14,500,000 |
| Cash Flow From Continuing Financing Activities | $-179,000 | $-218,000 | $103,864,000 | $15,798,000 |
| Net Other Financing Charges | $789,000 | $-218,000 | $-6,303,000 | $727,000 |
| Net Common Stock Issuance | $-168,000 | $0 | $110,167,000 | $13,000,000 |
| Issuance Of Capital Stock | - | $0 | $110,167,000 | $13,000,000 |
| Common Stock Issuance | - | $0 | $110,167,000 | $13,000,000 |
| Other | ||||
| Repayment Of Debt | $-800,000 | $0 | - | - |
| End Cash Position | $2,675,000 | $21,498,000 | $26,537,000 | $12,854,000 |
| Beginning Cash Position | $21,498,000 | $26,537,000 | $12,854,000 | $6,206,000 |
| Effect Of Exchange Rate Changes | $-22,000 | $-146,000 | $-306,000 | $122,000 |
| Changes In Cash | $-18,801,000 | $-4,893,000 | $13,989,000 | $6,526,000 |
| Common Stock Payments | $-168,000 | $0 | - | - |
| Net Issuance Payments Of Debt | $-800,000 | $0 | - | $15,000,000 |
| Net Short Term Debt Issuance | $-800,000 | $0 | - | - |
| Short Term Debt Payments | $-800,000 | $0 | - | - |
| Net Investment Purchase And Sale | $-6,278,000 | $-24,960,000 | $-36,806,000 | $0 |
| Sale Of Investment | $156,165,000 | $186,524,000 | $28,500,000 | $0 |
| Purchase Of Investment | $-162,443,000 | $-211,484,000 | $-65,306,000 | $0 |
| Net Business Purchase And Sale | $2,355,000 | $0 | $0 | $5,000,000 |
| Sale Of Business | $2,355,000 | $0 | $0 | $7,000,000 |
| Net Intangibles Purchase And Sale | $235,000 | $0 | - | - |
| Sale Of Intangibles | $270,000 | $0 | - | - |
| Purchase Of Intangibles | $-35,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-143,000 | $0 | $-2,000 | $3,702,000 |
| Purchase Of PPE | $-143,000 | $0 | $-2,000 | $-206,000 |
| Change In Working Capital | $-610,000 | $-92,000 | $-10,000 | $-989,000 |
| Change In Other Current Liabilities | $-1,008,000 | $796,000 | $3,606,000 | $93,000 |
| Change In Other Current Assets | $22,000 | $-27,000 | $130,000 | $63,000 |
| Change In Payables And Accrued Expense | $-8,000 | $-870,000 | $-15,000 | $300,000 |
| Change In Payable | $-8,000 | $-870,000 | $-15,000 | $300,000 |
| Change In Account Payable | $-146,000 | $-827,000 | $52,000 | $164,000 |
| Change In Prepaid Assets | $673,000 | $373,000 | $-3,545,000 | $-802,000 |
| Change In Receivables | $-289,000 | $-364,000 | $-186,000 | $-643,000 |
| Changes In Account Receivables | $-150,000 | $-117,000 | $74,000 | $-161,000 |
| Other Non Cash Items | $60,189,000 | $-6,478,000 | $1,830,000 | $28,000 |
| Stock Based Compensation | $2,296,000 | $2,188,000 | $-917,000 | $6,633,000 |
| Unrealized Gain Loss On Investment Securities | $-1,228,000 | $-2,696,000 | $0 | $-4,758,000 |
| Asset Impairment Charge | $20,000 | $334,000 | $79,141,000 | $7,724,000 |
| Amortization Of Securities | $-1,891,000 | $-1,195,000 | $0 | - |
| Depreciation Amortization Depletion | $225,000 | $78,000 | $72,000 | $70,000 |
| Depreciation And Amortization | $225,000 | $78,000 | $72,000 | $70,000 |
| Earnings Losses From Equity Investments | $422,000 | $203,000 | $575,000 | $-383,000 |
| Gain Loss On Investment Securities | $-2,213,000 | $-374,000 | $549,000 | $-4,758,000 |
| Gain Loss On Sale Of PPE | $-27,000 | $0 | $0 | $-749,000 |
| Gain Loss On Sale Of Business | $18,000 | $0 | - | - |
| Net Income From Continuing Operations | $-65,003,000 | $-8,693,000 | $-142,377,000 | $-23,061,000 |
| Purchase Of Business | - | $-5,100,000 | $0 | $-2,000,000 |
| Provisionand Write Offof Assets | - | $0 | $35,099,000 | $193,000 |
| Depreciation | - | $78,000 | $72,000 | - |
| Proceeds From Stock Option Exercised | - | - | $0 | $2,071,000 |
| Sale Of PPE | - | - | $0 | $3,702,000 |
| Deferred Tax | - | - | $0 | $6,000 |
| Deferred Income Tax | - | - | $0 | $6,000 |
| Issuance Of Debt | - | - | - | $15,000,000 |
| Net Long Term Debt Issuance | - | - | - | $15,000,000 |
| Long Term Debt Issuance | - | - | - | $15,000,000 |
| Change In Other Working Capital | - | - | - | $136,000 |
| Change In Accrued Expense | - | - | - | $0 |
| Change In Interest Payable | - | - | - | $0 |
| Pension And Employee Benefit Expense | - | - | - | $6,633,000 |